Monitoring inflammation status
AssigneeMologic Limited
InventorsGita Parekh, Paul Davis
Life of this patent
Estimating the term…
Abstract
Methods for monitoring inflammation status of a subject comprise determining levels of at least one neutrophil activation marker, or at least three markers, in urine samples taken from the subject at multiple time points, wherein increased levels of the at least one neutrophil activation marker, or at least one of the markers, in a urine sample are indicative of or predictive of an exacerbation of inflammation and/or wherein decreased levels of the at least one neutrophil activation marker, or at least one of the markers, in a urine sample following an increase are indicative or predictive of recovery from, or successful treatment of, an exacerbation of inflammation. Corresponding systems, test kits and computer programs are provided.
Claims8
A method comprising determining levels of at least three markers in urine samples taken from a subject suffering from chronic obstructive pulmonary disease (COPD) at multiple time points, wherein the at least three markers are selected from C-Reactive Protein (CRP), Clara Cell Protein (CC16), and Tissue Inhibitor of metalloproteinase (TIMP).
Dependencies are inferred from the claim text.